Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.51 +0.98 (+6.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2025)

Updated

Cullinan Therapeutics' Other Accumulated Expenses was $996,000 in Q4 2025, down 30.7% from $1.44 million a year earlier.

Analysis

Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

From Q4 2021 onward, Cullinan Therapeutics has reported Other Accumulated Expenses for 5 quarters.

  • Other Accumulated Expenses shows a four-year compound annual growth rate of 0.6% (FY2021 to FY2025).
  • In earlier years, Other Accumulated Expenses was $1.44 million in FY2024 (+57.2%), $914,000 in FY2023 (-53.2%), $1.96 million in FY2022 (+100.9%) and $973,000 in FY2021.
  • The Q4 2025 figure marks the lowest quarterly Other Accumulated Expenses since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cullinan Therapeutics 998.00 Mn 998.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 996,000.00
Dec 31, 2024 1.44 Mn
Dec 31, 2023 914,000.00
Dec 31, 2022 1.96 Mn
Dec 31, 2021 973,000.00
API Access

Cullinan Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CGEM&period=max&api_key=YOUR_API_KEY